CD86 and diabetes mellitus: Furthermore, CRAMP treatment inhibited increases in the ratio of inflammatory macrophages (M1 MΦ) versus regulatory macrophages (M2 MΦ) (Figure 6A) and the frequency of CD86+ cDCs in C. rodentium-accelerated diabetes (Figure 6B).